Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-01-06 @ 5:06 PM
Study NCT ID:
NCT05204368
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-16
First Post:
2022-01-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)
Sponsor:
Evopoint Biosciences Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
XNW4107-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None